Content and data provided by various third parties and Fidelity − Terms of Use | Help/Glossary
Research > ETFs > ETF / ETP Commentary > 

This Small-Cap ETF Could Find Its Groove

BY | ETF Database
09/18/2024 | 266 VIEWS
Small-cap stocks and the related exchange traded funds have moved in fits and starts this year. However, some market observers believe that with a recession unlikely, the asset class could be poised for a period of smoother upside.Should those outlooks prove accurate, the Invesco NASDAQ Future Gen 200 ETF (QQQS B+) could be a prime example of a small-cap ETF winner. With more than 81% of its roster allocated to healthcare and technology stocks, QQQS has clear leverage to lower interest rates. In the small-cap universe, those are capital-intensive sectors that often finance operations with debt. Investors often inversely correlate small-cap companies to interest rates. Lower interest rates could also spur increased consolidation activity in the biotechnology arena. This could be a catalyst for QQQS; many small-cap healthcare names are biotech firms. The interest rate catalyst is valid, but what’s important for investors mulling QQQS is that there are potential sparks for smaller stocks.QQQS Tailwinds Could EmergeClearly, QQQS is sector-heavy at the top. It’s also possible some of the ETF’s smaller sector exposures could contribute to near- to medium-term upside. “US small caps have underperformed US large caps, but so have most other major markets. In the US, the underperformance reflects the strong returns (at least until recently) of mega-cap US technology stocks. However, relative to the non-tech parts of the market, US small cap stocks have done well,” observed Daniel Morris of BNP Paribas. Another point in favor of QQQS is that the U.S. economy, while cooling, is still growing and appears unlikely to enter a recession. That could support steady confidence among consumers, potentially bolstering the allure more domestically focused corners of the equity market. Small-caps check that box. On a related note, Election Day is less than two months away and electoral politics can and do affect stocks. It’s likely the presidential election will be close. It’s outcome obviously isn’t known, but there are avenues through which small-cap stocks could benefit. “As the US economy is still in growth mode, that positive performance should continue. If Donald Trump is re-elected to the White House, the prospect for higher tariffs (and hence greater demand for goods and services produced in the US) should provide a further boost to small-cap companies,” concluded Morris. For more news, information, and analysis, visit the ETF Education Channel.

More Commentary

Active ETFs Offer Tax Perks, Too
BY | ETF Database
4:50 am ET 11/21/24 | 48 VIEWS
Sell on the Pop Prospects: November 20 Edition
BY | ETF Database
11/20/2024 | 24 VIEWS
The Case for Active Investing in 2025
BY | ETF Database
11/20/2024 | 59 VIEWS
View more Commentary

Search Commentary

Enter Keyword(s)
Filter Results

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.

Copyright 1998–2024 FMR LLC. 
All rights reserved.